Eisai Foreign Patent

Eisai Foreign Patent. Any patent issued outside the United States that includes a claim which encompasses the use of zonisamide as the sole active ingredient to treat obesity or other weight-related disorders or conditions that (a) issues from any patent application (such as a national phase application) based on PCT Application No. PCT/US03/14459 filed on May 5, 2003, or (b) issues from any other patent application filed outside the United States claiming in whole or in part the benefit of the filing date of, or... which is otherwise based on the disclosure in, PCT Application No. PCT/US03/14459 filed on May 5, 2003, U.S. Patent Application No. 10/429,474 filed on May 2, 2003 or U.S. Provisional Application No. 60/378,446 filed on May 6, 2002. View More